Method of judging grade of malignancy of carcinoma cell using ATBF-1
View Patent ↗Means for easily determining the grade of malignancy of cancer cells. The amount of ATBF1 in the whole cell structure of test cancer cells separated from a living organism is detected, and on the basis of detection results, the grade of malignancy of test cancer cells is judged. Alternatively, the amount of ATBF1 in the nuclei of test cancer cells separated from a living organism is detected, and on the basis of detection results, the grade of malignancy of test cancer cells is judged. Still alternatively, the amount of ATBF1 in the cytoplasms of test cancer cells separated from a living organism is detected, and on the basis of detection results, the grade of malignancy of test cancer cells is judged. In a preferred from, at least one of (1) the amount of intranuclear presence and/or intracytoplasmic presence a region corresponding to exon 10 of an ATBF1 gene, (2) the amount of intranuclear presence and/or intracytoplasmic presence a region corresponding to exon 11 of an ATBF1 gene, and (3) the amount of intranuclear presence and/or intracytoplasmic presence a region corresponding to exon 3 of an ATBF1 gene is detected as the amount of ATBF1.
1. A method of determining a grade of malignancy of a test cancer cell, the method comprising the following steps:
detecting an intranuclear amount and intracytoplasmic amount of a first region corresponding to exon 10 of an ATBF1 gene and/or a second region corresponding to exon 11 of an ATBF1 gene in the test cancer cell; and
determining a grade of malignancy of the test cancer cell according to the following criteria: (a) the grade of malignancy is low when the first region is localized mainly in a nucleus, (b) the grade of malignancy is high when the first region is localized mainly in a cytoplasm, (c) the grade of malignancy is higher than that of (b) when the first region is absent both in the cytoplasm and in the nucleus, (d) the grade of malignancy is low when the second region is localized mainly in the nucleus, and (e) the grade of malignancy is high when the second region is localized mainly in the cytoplasm.
2. The method of determining a grade of malignancy according to claim 1 , further comprising the step of:
detecting the intranuclear amount and intracytoplasmic amount of a region corresponding to exon 3 of an ATBF1 gene.
3. The method of determining a grade of malignancy according to claim 1 , wherein the detection is carried out by using an immunohistochemical staining method.
4. A method of determining a grade of malignancy of a test cancer cell, the method comprising the following steps:
detecting an intranuclear amount and intracytoplasmic amount of a first region corresponding to exon 10 of an ATBF1 gene and/or a second region corresponding to exon 11 of an ATBF1 gene in the test cancer cell;
detecting the intranuclear amount and intracytoplasmic amount of a third region corresponding to exon 3 of an ATBF1 gene in the test cancer cell; and
determining a grade of malignancy of the test cancer cell wherein the grade of malignancy is high when the first region is absent both in the cytoplasm and in the nucleus.
5. The method of determining a grade of malignancy according to claim 4 , wherein the detection is carried out by using an immunohistochemical staining method.